Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests

Experimental Animals

Volumn 63, Issue 3, 2014, Pages 277-287

  Damián, Juan P ^a,b   Acosta, Victoria ^a   Da Cuña, Maira ^a   Ramírez, Isara ^a   Oddone, Natalia ^a   Zambrana, Ana ^a   Bervejillo, Verónica ^a   Benech, Juan C ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Diabetes; Flavonoid; Mouse; Resveratrol; Stress

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANXIOLYTIC AGENT; RESVERATROL; STILBENE DERIVATIVE; STREPTOZOCIN;

ADAPTIVE BEHAVIOR; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; DEFECATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GROOMING; MALE; MICTURITION; MOTOR ACTIVITY; MOUSE; PSYCHOLOGY; TIME;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; ANTI-ANXIETY AGENTS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; ANXIETY; BEHAVIOR, ANIMAL; DEFECATION; DIABETES MELLITUS, EXPERIMENTAL; GROOMING; MALE; MICE; MOTOR ACTIVITY; STILBENES; STREPTOZOCIN; TIME FACTORS; URINATION;

EID: 84905182845     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.63.277     Document Type: Article

References (84)

1. Abraham, P.M., Kuruvilla, K.P., Mathew, J., Malat, A., Joy, S., and Paulose, C.S. 2010. Alterations in hippocampal serotonergic and INSR function in streptozotocin induced diabetic rats exposed to stress: neuroprotective role of pyridoxine and Aegle marmelose. J. Biomed. Sci. 17: 78. [Medline] [CrossRef]
2. Akbarzadeh, A., Norouzian, D., Mehrabi, M.R., Jamshidi, S., Farhangi, A., Verdi, A.A., Mofidian, S.M., and Rad, B.L. 2007. Induction of diabetes by Streptozotocin in rats. Indian J. Clin. Biochem. 22: 60-64. [Medline] [CrossRef]
3. Alvarez, E.O., Beauquis, J., Revsin, Y., Banzan, A.M., Roig, P., De Nicola, A.F., and Saravia, F. 2009. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav. Brain Res. 198: 224-230. [Medline] [CrossRef]
4. Anderson, R.J., Freedland, K.E., Clouse, R.E., and Lustman, P.J. 2001. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24: 1069-1078. [Medline] [CrossRef]
5. Athar, M., Back, J.H., Tang, X., Kim, K.H., Kopelovich, L., Bickers, D.R., and Kim, A.L. 2007. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 224: 274-283. [Medline] [CrossRef]
6. Bagdy, G., Kalogeras, K.T., and Szemeredi, K. 1992. Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations. Eur. J. Pharmacol. 229: 9-14. [Medline] [CrossRef]
7. Bannerman, D.M., Grubb, M., Deacon, R.M., Yee, B.K., Feldon, J., and Rawlins, J.N. 2003. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav. Brain Res. 139: 197-213. [Medline] [CrossRef]
8. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R., and Sinclair, D.A. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342. [Medline] [CrossRef]
9. Baur, J.A. and Sinclair, D.A. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5: 493-506. [Medline] [CrossRef]
10. Belviranli, M., Atalik, K.E., Okudan, N., and Gökbel, H. 2012. Age and sex affect spatial and emotional behaviors in rats: the role of repeated elevated plus maze test. Neuroscience 227: 1-9. [Medline] [CrossRef]
11. Belzung, C. and Griebel, G. 2001. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125: 141-149. [Medline] [CrossRef]
12. Beninger, R.J., Mazurski, E.J., and Hoffman, D.C. 1991. Receptor subtype-specific dopaminergic agents and unconditioned behavior. Pol. J. Pharmacol. Pharm. 43: 507-528. [Medline]
13. Berridge, K.C. 1990. Comparative fine structure of action: rules of form and sequence in the grooming patterns of six rodent species. Behaviour 113: 21-56. [CrossRef]
14. Berridge, K.C. and Aldridge, J.W. 2000. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Synapse 37: 194-204. [Medline] [CrossRef]
15. Bitar, M., Koulu, M., Rapoport, S.I., and Linnoila, M. 1986. Diabetes-induced alteration in brain monoamine metabolism in rats. J. Pharmacol. Exp. Ther. 236: 432-437. [Medline]
16. Brenes, J.C., Padilla, M., and Fornaguera, J. 2009. A detailed analysis of open-field habituation and behavioral and neurochemical antidepressant-like effects in postweaning enriched rats. Behav. Brain Res. 197: 125-137. [Medline] [CrossRef]
17. Brenes, J.C., Rodríguez, O., and Fornaguera, J. 2008. Differential effect of environment enrichment and social isolation on depressive-like behavior, spontaneous activity and serotonin and norepinephrine concentration in prefrontal cortex and ventral striatum. Pharmacol. Biochem. Behav. 89: 85-93. [Medline] [CrossRef]
18. Broom, D.M. 1986. Indicators of poor welfare. Br. Vet. J. 142: 524-526. [Medline] [CrossRef]
19. Bruhwyler, J., Chleide, E., Liégeois, J.F., Delarge, J., and Mercier, M. 1991. Effects of specific dopaminergic agonists and antagonists in the open-field test. Pharmacol. Biochem. Behav. 39: 367-371. [Medline] [CrossRef]
20. Busanello, A., Peroza, L.R., Wagner, C., Sudati, J.H., Pereira, R.P., Prestes, A.S., Rocha, J.B., Fachinetto, R., and Barbosa, N.B. 2012. Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine. Pharmacol. Biochem. Behav. 101: 307-310. [Medline] [CrossRef]
21. Candland, D.K. and Nagy, Z.M. 1969. The open field: some comparative data. Ann. N. Y. Acad. Sci. 159: 831-851. [Medline] [CrossRef]
22. Crawley, J.N., Belknap, J.K., Collins, A., Crabbe, J.C., Frankel, W., Henderson, N., Hitzemann, R.J., Maxson, S.C., Miner, L.L., Silva, A.J., Wehner, J.M., Wynshaw-Boris, A., and Paylor, R. 1997. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl.) 132: 107-124. [Medline] [CrossRef]
23. Cromwell, H.C., Berridge, K.C., Drago, J., and Levine, M.S. 1998. Action sequencing is impaired in D1A-deficient mutant mice. Eur. J. Neurosci. 10: 2426-2432. [Medline] [CrossRef]
24. Chan, O., Inouye, K., Riddell, M.C., Vranic, M., and Matthews, S.G. 2003. Diabetes and the hypothalamo-pituitaryadrenal (HPA) axis. Minerva Endocrinol. 28: 87-102. [Medline]
25. Chen, C.C. and Yang, J.C. 1991. Effects of short and longlasting diabetes mellitus on mouse brain monoamines. Brain Res. 552: 175-179. [Medline] [CrossRef]
26. Chen, K.H., Hung, C.C., Hsu, H.H., Jing, Y.H., Yang, C.W., and Chen, J.K. 2011. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-in- duced diabetic rats. Chem. Biol. Interact. 190: 45-53. [Medline] [CrossRef]
27. Chen, Y., Tseng, S.H., Lai, H.S., and Chen, W.J. 2004. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136: 57-66. [Medline] [CrossRef]
28. Chinen, C.C. and Frussa-Filho, R. 1999. Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice. Neuropsychopharmacology 21: 670-678. [Medline] [CrossRef]
29. Doron, R., Lotan, D., Rak-Rabl, A., Raskin-Ramot, A., Lavi, K., and Rehavi, M. 2012. Anxiolytic effects of a novel herbal treatment in mice models of anxiety. Life Sci. 90: 995-1000. [Medline] [CrossRef]
30. Enginar, N., Hatipoǧlu, I., and Firtina, M. 2008. Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats. Pharmacol. Biochem. Behav. 89: 450-455. [Medline] [CrossRef]
31. Fischer, A., Sananbenesi, F., Pang, P.T., Lu, B., and Tsai, L.H. 2005. Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48: 825-838. [Medline] [CrossRef]
32. Fraga, M.C., Moura, E.G., Silva, J.O., Bonomo, I.T., Filgueiras, C.C., Abreu-Villaça, Y., Passos, M.C., Lisboa, P.C., and Manhães, A.C. 2011. Maternal prolactin inhibition at the end of lactation affects learning/memory and anxiety-like behaviors but not novelty-seeking in adult rat progeny. Pharmacol. Biochem. Behav. 100: 165-173. [Medline] [CrossRef]
33. Frémont, L. 2000. Biological effects of resveratrol. Life Sci. 66: 663-673. [Medline] [CrossRef]
34. Gacar, N., Mutlu, O., Utkan, T., Komsuoglu Celikyurt, I., Gocmez, S.S., and Ulak, G. 2011. Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats. Pharmacol. Biochem. Behav. 99: 316-323. [Medline] [CrossRef]
35. Gentsch, C., Lichtsteiner, M., and Feer, H. 1987. Open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide. Behav. Brain Res. 25: 101-107. [Medline] [CrossRef]
36. Gispen, W.H. and Isaacson, R.L. 1981. ACTH-induced excessive grooming in the rat. Pharmacol. Ther. 12: 209-246. [Medline] [CrossRef]
37. Graf, M., Kantor, S., Anheuer, Z.E., Modos, E.A., and Bagdy, G. 2003. m-CPP-induced self-grooming is mediated by 5-HT2C receptors. Behav. Brain Res. 142: 175-179. [Medline] [CrossRef]
38. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., Scherer, B., and Sinclair, D.A. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196. [Medline] [CrossRef]
39. Joffe, I.I., Travers, K.E., Perreault-Micale, C.L., Hampton, T., Katz, S.E., Morgan, J.P., and Douglas, P.S. 1999. Abnormal cardiac function in the streptozotocin-induced noninsulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J. Am. Coll. Cardiol. 34: 2111-2119. [Medline] [CrossRef]
40. Kajiyama, Y., Iijima, Y., Chiba, S., Furuta, M., Ninomiya, M., Izumi, A., Shibata, S., and Kunugi, H. 2010. Prednisolone causes anxiety- and depression-like behaviors and altered expression of apoptotic genes in mice hippocampus. Prog. Neuropsychopharmacol. Biol. Psychiatry 34: 159-165. [Medline] [CrossRef]
41. Kalueff, A.V. and Tuohimaa, P. 2004. Grooming analysis algorithm for neurobehavioural stress research. Brain Res. Brain Res. Protoc. 13: 151-158. [Medline] [CrossRef]
42. Kalueff, A.V. and Tuohimaa, P. 2005. The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J. Neurosci. Methods 143: 169-177. [Medline] [CrossRef]
43. Kennett, G.A., Whitton, P., Shah, K., and Curzon, G. 1989. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur. J. Pharmacol. 164: 445-454. [Medline] [CrossRef]
44. Kim, D., Nguyen, M.D., Dobbin, M.M., Fischer, A., Sananbenesi, F., Rodgers, J.T., Delalle, I., Baur, J.A., Sui, G., Armour, S.M., Puigserver, P., Sinclair, D.A., and Tsai, L.H. 2007. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 26: 3169-3179. [Medline] [CrossRef]
45. Koo, S.H. and Montminy, M. 2006. In vino veritas: a tale of two sirt1s? Cell 127: 1091-1093. [Medline] [CrossRef]
46. Kumar, A. and Sharma, S.S. 2010. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun. 394: 360-365. [Medline] [CrossRef]
47. Lacković, Z., Salković, M., Kuci, Z., and Relja, M. 1990. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54: 143-147. [Medline] [CrossRef]
48. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., and Auwerx, J. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122. [Medline] [CrossRef]
49. Le Foll, B., Diaz, J., and Sokoloff, P. 2005. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci. 76: 1281-1296. [Medline] [CrossRef]
50. Leedom, L.J., Meehan, W.P., and Zeidler, A. 1987. Avoidance responding in mice with diabetes mellitus. Physiol. Behav. 40: 447-451. [Medline] [CrossRef]
51. Leone, T.C., Lehman, J.J., Finck, B.N., Schaeffer, P.J., Wende, A.R., Boudina, S., Courtois, M., Wozniak, D.F., Sambandam, N., Bernal-Mizrachi, C., Chen, Z., Holloszy, J.O., Medeiros, D.M., Schmidt, R.E., Saffitz, J.E., Abel, E.D., Semenkovich, C.F., and Kelly, D.P. 2005. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 3: e101. [Medline] [CrossRef]
52. Lever, C., Burton, S., and O'Keefe, J. 2006. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev. Neurosci. 17: 111-133. [Medline] [CrossRef]
53. Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.Y., Mootha, V.K., Jäger, S., Vianna, C.R., Reznick, R.M., Cui, L., Manieri, M., Donovan, M.X., Wu, Z., Cooper, M.P., Fan, M.C., Rohas, L.M., Zavacki, A.M., Cinti, S., Shulman, G.I., Lowell, B.B., Krainc, D., and Spiegelman, B.M. 2004. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119: 121-135. [Medline] [CrossRef]
54. M arfella, R., Di Filippo, C., Esposito, K., Nappo, F., Piegari, E., Cuzzocrea, S., Berrino, L., Rossi, F., Giugliano, D., and D'Amico, M. 2004. Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 53: 454-462. [Medline] [CrossRef]
55. M iyata, S., Yamada, N., Hirano, S., Tanaka, S., and Kamei, J. 2007. Diabetes attenuates psychological stress-elicited 5-HT secretion in the prefrontal cortex but not in the amygdala of mice. Brain Res. 1147: 233-239. [Medline] [CrossRef]
56. Moody, T.W., Merali, Z., and Crawley, J.N. 1988. The effects of anxiolytics and other agents on rat grooming behavior. Ann. N. Y. Acad. Sci. 525: 281-290. [Medline] [CrossRef]
57. N ielsen, L.B., Bartels, E.D., and Bollano, E. 2002. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J. Biol. Chem. 277: 27014-27020. [Medline] [CrossRef]
58. Penumathsa, S.V., Thirunavukkarasu, M., Zhan, L., Maulik, G., Menon, V.P., Bagchi, D., and Maulik, N. 2008. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J. Cell. Mol. Med. 12:(6A): 2350-2361. [Medline] [CrossRef]
59. Permutt, M.A., Wasson, J., and Cox, N. 2005. Genetic epidemiology of diabetes. J. Clin. Invest. 115: 1431-1439. [Medline] [CrossRef]
60. Pietropaolo, S., Branchi, I., Cirulli, F., Chiarotti, F., Aloe, L., and Alleva, E. 2004. Long-term effects of the periadolescent environment on exploratory activity and aggressive behaviour in mice: social versus physical enrichment. Physiol. Behav. 81: 443-453. [Medline] [CrossRef]
61. Ramanathan, M., Jaiswal, A., and Bhattacharya, S. 1997. Brain monoamines and metabolites during early streptozotocin- induced diabetes in rats. Biog. Amines 13: 55-63.
62. Ramanathan, M., Jaiswal, A.K., and Bhattacharya, S.K. 1998. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats. Psychopharmacology (Berl.) 135: 361-367. [Medline] [CrossRef]
63. Reijmer, Y.D., van den Berg, E., Ruis, C., Kappelle, L.J., and Biessels, G.J. 2010. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab. Res. Rev. 26: 507-519. [Medline] [CrossRef]
64. Rogina, B. and Helfand, S.L. 2004. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA 101: 15998-16003. [Medline] [CrossRef]
65. Sachs, B.D. 1988. The development of grooming and its expression in adult animals. Ann. N. Y. Acad. Sci. 525: 1-17. [Medline] [CrossRef]
66. Saiko, P., Szakmary, A., Jaeger, W., and Szekeres, T. 2008. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat. Res. 658: 68-94. [Medline] [CrossRef]
67. S aravia, F.E., Gonzalez, S.L., Roig, P., Alves, V., Homo-Delarche, F., and De Nicola, A.F. 2001. Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse. Cell. Mol. Neurobiol. 21: 15-27. [Medline] [CrossRef]
68. Schmatz, R., Mazzanti, C.M., Spanevello, R., Stefanello, N., Gutierres, J., Corrêa, M., da Rosa, M.M., Rubin, M.A., Chitolina Schetinger, M.R., and Morsch, V.M. 2009. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 610: 42-48. [Medline] [CrossRef]
69. S chmatz, R., Perreira, L.B., Stefanello, N., Mazzanti, C., Spanevello, R., Gutierres, J., Bagatini, M., Martins, C.C., Abdalla, F.H., Daci da Silva Serres, J., Zanini, D., Vieira, J.M., Cardoso, A.M., Schetinger, M.R., and Morsch, V.M. 2012. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 94: 374-383. [Medline] [CrossRef]
70. S hiomi, T., Tsutsui, H., Ikeuchi, M., Matsusaka, H., Hayashidani, S., Suematsu, N., Wen, J., Kubota, T., and Takeshita, A. 2003. Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J. Am. Coll. Cardiol. 42: 165-172. [Medline] [CrossRef]
71. Silan, C. 2008. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 31: 897-902. [Medline] [CrossRef]
72. Spruijt, B.M., van Hooff, J.A., and Gispen, W.H. 1992. Ethology and neurobiology of grooming behavior. Physiol. Rev. 72: 825-852. [Medline]
73. S toessl, A.J. 1994. Dopamine D1 receptor agonist-induced grooming is blocked by the opioid receptor antagonist naloxone. Eur. J. Pharmacol. 259: 301-303. [Medline] [CrossRef]
74. Sulaiman, M., Matta, M.J., Sunderesan, N.R., Gupta, M.P., Periasamy, M., and Gupta, M. 2010. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium AT Pase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 298: H833-H843. [Medline] [CrossRef]
75. T hirunavukkarasu, M., Penumathsa, S.V., Koneru, S., Juhasz, B., Zhan, L., Otani, H., Bagchi, D., Das, D.K., and Maulik, N. 2007. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic. Biol. Med. 43: 720-729. [Medline] [CrossRef]
76. Trulson, M.E. and Himmel, C.D. 1985. Effects of insulin and streptozotocin-induced diabetes on brain norepinephrine metabolism in rats. J. Neurochem. 44: 1873-1876. [Medline] [CrossRef]
77. Tuli, J.S., Smith, J.A., and Morton, D.B. 1995. Stress measurements in mice after transportation. Lab. Anim. 29: 132-138. [Medline] [CrossRef]
78. Uriarte, N., Ferreira, A., Rosa, X.F., Sebben, V., and Lucion, A.B. 2008. Overlapping litters in rats: effects on maternal behavior and offspring emotionality. Physiol. Behav. 93: 1061-1070. [Medline] [CrossRef]
79. Vissiennon, C., Nieber, K., Kelber, O., and Butterweck, V. 2012. Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin- are they prodrugs? J. Nutr. Biochem. 23: 733-740. [Medline] [CrossRef]
80. Wessels, A.M., Scheltens, P., Barkhof, F., and Heine, R.J. 2008. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur. J. Pharmacol. 585: 88-96. [Medline] [CrossRef]
81. Xu, Y., Wang, Z., You, W., Zhang, X., Li, S., Barish, P.A., Vernon, M.M., Du, X., Li, G., Pan, J., and Ogle, W.O. 2010. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur. Neuropsychopharmacol. 20: 405-413. [Medline] [CrossRef]
82. Zarrindast, M.R., Babapoor-Farrokhran, S., Babapoor-Farrokhran, S., and Rezayof, A. 2008. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci. 82: 1175-1181. [Medline] [CrossRef]
83. Zhang, L.M., Yao, J.Z., Li, Y., Li, K., Chen, H.X., Zhang, Y.Z., and Li, Y.F. 2012. Anxiolytic effects of flavonoids in animal models of posttraumatic stress disorder. Evid. Based Complement. Alternat. Med. 2012: 623753. [Medline]
84. Zunino, S.J., Storms, D.H., Newman, J.W., Pedersen, T.L., Keen, C.L., and Ducore, J.M. 2012. Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model. Int. J. Oncol. 40: 1277-1284. [Medline]